NVCR NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Novocure Ltd · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 14.84 USD
-15.9% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 4.0% above the Trend Line and sits at 43.2% of its 52-week range. The latest completed week returned -15.9%, after a -13.7% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is expensive relative to peers. Options positioning is volatility with 57/100 conviction, while the latest news-sentiment score is 58/100. Near-term considerations: volume confirmation is below normal.

Setup score 34 out of 100
Latest Close 14.84 USD 31 Jul 2026
1W Return -15.9% latest completed week
4W Return -13.7% short-term follow-through
12W Return -17.0% quarterly tape
Trend Breadth 25.0% 13 of 52 weeks active
Volume Ratio 0.9x vs 13-week average
What is working
  • The trend backdrop is active with a 13-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 42.46% based on similar historical setup states.
  • The share remains more than 20% below its 52-week high.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -15.9% Latest completed week; four-week move -13.7%. Indicator stack 59/46 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 42.46% Historical one-week expectancy contributes to the evidence score when direction is confirmed. Options pressure Volatility 57/100 conviction; expected move 12.5%. News sentiment 58/100 66 relevant articles in the latest sentiment read. Event risk 23 Jul Latest stored earnings date was 23 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 4.0% above the Trend Line and sits at 43.2% of its 52-week range. The latest completed week returned -15.9%, after a -13.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.9x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7512-week average 0.62

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.75Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -13.7% over four weeks, -17.0% over 12 weeks, and 31.1% over one year. The current trend has remained active for 13 consecutive weeks.

Performance by holding period

1W-15.9%
4W-13.7%
12W-17.0%
26W19.7%
52W31.1%
Active trend streak13 weeks
Active weeks in one year13
Trend breadth25.0%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.13Latest activity-pressure read.
Pressure change-81.1%Four-week change in activity pressure.
Leadership0.82Latest relative-leadership reading.
RS change-93.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is expensive relative to peers.

Open full factor analysis
Factor week 02 Aug 2026 Financial statements through 30 Jun 2026 Field coverage 85% Model confidence 85%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength17/100Blend of value, momentum, and quality. Underlying universe rank 84; rank 1 is best.
Value18/100Relative valuation strength. Underlying universe rank 83; rank 1 is best.
Quality14/100Profitability and accounting quality. Underlying universe rank 87; rank 1 is best.
Momentum85/100Medium-term price momentum. Underlying universe rank 16; rank 1 is best.
Growth71/100Revenue and earnings growth. Underlying universe rank 30; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
2.5x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
1.3%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
76.1%
Gross profit retained from each unit of revenue.
Operating margin
-21.3%
Operating profit retained from revenue.
Free-cash-flow margin
3.4%
Free cash flow generated from revenue.
Return on invested capital
-23.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
11.0%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
3/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.2%
Net share repurchases relative to market value.
Shareholder yield
-0.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-1.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

NVCR shows volatility options pressure with a 57/100 conviction score, put-call volume ratio of 0.08, expected move of 12.5%, and Sharemaestro trend signal active.

Conviction57/100
Expected move12.5%
Put/call volume0.08
Pressure95
Speculation24
Volatility94
Trend agreement8
Open options detail
Insider activity19 / 1

19 acquisitions and 1 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment58/100

Weighted news tone is neutral across 66 relevant articles.

25 positive · 35 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings23 JulLatest stored earnings date was 23 Jul 2026.
Options expected move12.5%Nearest-chain priced movement where available.
52-week drawdown-30.8%Distance below the 52-week high.
13-week volatility9.2%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher13 of 2613 weeks finished lower.
Best week+33.3%Week of 1 May.
Worst week-19.7%Week of 19 Jun.
Latest week-15.9%Week of 31 Jul.

Shape of recent returns

Strong gains8
Modest gains5
Flat weeks0
Modest losses5
Sharp losses8
Recent vol9.2%13-week weekly-return volatility.
Base vol9.5%52-week weekly-return volatility.
Up/down split25/27Count of positive and negative weeks in the 52-week window.
Average skew8.2% / -5.8%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape41/100

Trend, activity pressure, participation, and risk combine to a 41/100 tape read.

 Indicator analysis85/100

Latest 12-week confirmation: trend 12/12, activity pressure 12/12, relative leadership 11/12.

Activity pressure 0.75; No reversal markers Next-Week ExpectancyNegative 42.46%

Next-week expectancy is negative with a 42.46% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors30/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 73; Small Cap Core rank 89 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options39/100

NVCR shows volatility options pressure with a 57/100 conviction score, put-call volume ratio of 0.08, expected move of 12.5%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 12.5% Sentiment58/100

Weighted news tone is neutral across 66 relevant articles.

NVCR Stock Gains After Novocure Announces Positive Topline Results In Metastatic Pancreatic Cancer Therapy Trial Insiders19 / 1

19 acquisitions and 1 disposals in the latest 180-day insider tape.

 Earnings23 Jul

Latest stored earnings date was 23 Jul 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202614.84 USD-15.9%14.27 USD16.64 USD0.130.827.3MOn
24 Jul 202617.65 USD10.9%14.21 USD16.73 USD0.4220.6815.9MOn
17 Jul 202615.92 USD-2.3%14.07 USD16.83 USD0.427.555.1MOn
10 Jul 202616.30 USD-5.2%13.97 USD16.98 USD0.584.999.1MOn
3 Jul 202617.20 USD11.5%13.87 USD17.13 USD0.6911.855.8MOn
26 Jun 202615.43 USD8.1%13.70 USD17.28 USD0.860.509.8MOn
19 Jun 202614.28 USD-19.7%13.61 USD17.45 USD0.98-12.049.9MOn
12 Jun 202617.78 USD3.6%13.53 USD17.63 USD1.2011.226.1MOn
5 Jun 202617.16 USD0.7%13.32 USD17.80 USD1.338.999.1MOn
29 May 202617.04 USD-5.1%13.11 USD17.96 USD1.432.666.0MOn
22 May 202617.96 USD2.2%12.97 USD18.36 USD1.5710.036.1MOn
15 May 202617.58 USD-1.7%12.83 USD18.72 USD1.237.968.2MOn
8 May 202617.89 USD7.6%12.70 USD19.12 USD0.848.6310.4MOn
1 May 202616.62 USD33.3%12.55 USD19.48 USD0.195.5414.8MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.